{"id":421,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2021-06-15","marketCap":12.415976524353027,"name":"Alzamend Neuro Inc","phone":"18447226333.0","outstanding":6.460000038146973,"symbol":"ALZN","website":"https://alzamend.com/","industry":"Biotechnology"},"price":1.793,"year":2023,"month":11,"day":4,"weekday":"Saturday","title":"Impact of currency fluctuations on Alzamend Neuro Inc multinational stock","date":"2023-11-04","url":"/posts/2023/11/04/ALZN","content":[{"section":"Positive Impact","text":"Currency fluctuations can positively impact Alzamend Neuro Inc's multinational stock when the company's currency weakens against the local currency in the countries where it operates. This can result in increased competitiveness of Alzamend Neuro Inc's products in those markets as they become relatively cheaper. Additionally, when the company repatriates profits from these countries, the weaker currency can lead to higher profits in the company's home currency."},{"section":"Real-world Case Study: Alzamend Neuro Inc and the Euro","text":"For example, if Alzamend Neuro Inc operates in Europe and the USD strengthens against the Euro, it will make the company's products relatively cheaper for European consumers. This can lead to increased sales and potentially higher stock prices for Alzamend Neuro Inc."},{"section":"Negative Impact","text":"On the other hand, currency fluctuations can negatively impact Alzamend Neuro Inc's multinational stock when the company's currency strengthens against the local currency in the countries where it operates. This can result in decreased competitiveness of Alzamend Neuro Inc's products as they become relatively more expensive. It can also lead to lower profits when repatriating earnings from these countries."},{"section":"Real-world Case Study: Alzamend Neuro Inc and the British Pound","text":"If Alzamend Neuro Inc operates in the UK and the USD weakens against the British Pound, it will make the company's products relatively more expensive for British consumers. This can lead to decreased sales and potentially lower stock prices for Alzamend Neuro Inc."},{"section":"Balanced Assessment of Currency Risk","text":"Currency risk is a significant consideration for multinational companies like Alzamend Neuro Inc. While currency fluctuations can create both opportunities and challenges, the impact on the company's stock is not solely determined by currency fluctuations. Other factors such as market conditions, company performance, and overall economic factors also play a crucial role in shaping the stock price. Therefore, it is important for investors to assess currency risk in conjunction with other risk factors before making investment decisions."}],"tags":["CrossOver55","Long","Biotechnology"],"news":[{"category":"company","date":1698858874,"headline":"Alzamend Neuro (ALZN) Price Target Increased by 1306.25% to 57.38","id":123546834,"image":"","symbol":"ALZN","publisher":"Fintel","summary":"","url":"https://fintel.io/news/alzamend-neuro-alzn-price-target-increased-by-130625-to-5738-518"},{"category":"company","date":1698670620,"headline":"Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session","id":123500930,"image":"","symbol":"ALZN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185401147"},{"category":"company","date":1698667200,"headline":"Alzamend Neuro Announces Reverse Stock Split","id":123501404,"image":"https://media.zenfs.com/en/business-wire.com/0a738c4335e294256ab613172c3b436f","symbol":"ALZN","publisher":"Yahoo","summary":"ATLANTA, October 30, 2023--Alzamend Neuro Announces Reverse Stock Split","url":"https://finance.yahoo.com/news/alzamend-neuro-announces-reverse-stock-120000789.html"},{"category":"company","date":1698664800,"headline":"Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher","id":123500097,"image":"","symbol":"ALZN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185261700"},{"category":"company","date":1698655980,"headline":"Nasdaq Gains Over 1%; McDonald's Reports Upbeat Earnings","id":123500067,"image":"","symbol":"ALZN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185062240"},{"category":"company","date":1698651480,"headline":"Alzamend Neuro stock plummets on 1-for-15 reverse stock split","id":123500547,"image":"","symbol":"ALZN","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184968404"},{"category":"company","date":1698650160,"headline":"Alzamend Neuro annouces one-for-fifteen reverse stock split","id":123500548,"image":"","symbol":"ALZN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184944941"},{"category":"company","date":1698631800,"headline":"Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies","id":123506091,"image":"","symbol":"ALZN","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185510206"},{"category":"company","date":1698152160,"headline":"Promising Developments in Alzamend Neuro’s Clinical Trials Bolster Buy Rating: A Focused Review on AL001’s Potential in Mental Health Treatment","id":123368956,"image":"","symbol":"ALZN","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175541584"},{"category":"company","date":1698067870,"headline":"EXCLUSIVE: Alzamend Neuro Submits IND For Phase IIA Trial Of Next-Gen Lithium Candidate In Major Depressive Disorder","id":123336311,"image":"https://media.zenfs.com/en/Benzinga/9da4c011561d648a8568e336582b680e","symbol":"ALZN","publisher":"Yahoo","summary":"Alzamend Neuro Inc (NASDAQ: ALZN) has submitted an investigational new drug (IND) application to the FDA to initiate AL001-MDD01, a Phase IIA plasma/brain pharmacokinetics clinical study of AL001 for adjunctive treatment of patients with major depressive disorder (MDD). Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for treating Alzheimer’s, BD, MDD, and PTSD. Lithium, although not FDA-approved for MDD augmentation, has been used off-label for y","url":"https://finance.yahoo.com/news/exclusive-alzamend-neuro-submits-ind-133110652.html"},{"category":"company","date":1698062400,"headline":"Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Major Depressive Disorder Patients of its Next‑Generation Lithium Therapeutic Drug Candidate AL001","id":123336312,"image":"https://media.zenfs.com/en/business-wire.com/ccbe5b63f8f06740b0d8332f01eea504","symbol":"ALZN","publisher":"Yahoo","summary":"ATLANTA, October 23, 2023--Alzamend Neuro Submit IND Application for Phase IIA Clinical Trial for Major Depressive Disorder of Its Next-Generation Lithium Therapeutic Drug AL001","url":"https://finance.yahoo.com/news/alzamend-neuro-submits-ind-application-120000163.html"},{"category":"company","date":1698045060,"headline":"Alzamend Neuro submits AL001-MDD01 IN application to FDA","id":123352697,"image":"","symbol":"ALZN","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3173221981"}]}